Healthcare
Monday, June 27, 2016
BRIEF-DBV Technologies completes recruitment global phase III study of viaskin peanut
* Announces on Monday the completion of recruitment in
global phase III study of viaskin peanut for the treatment of
peanut allergic children
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment